logo

Leap © 2017
powerd by DC&D Communicatie

Leap | 2015 april
0
archive,date,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,side_area_uncovered_from_content,footer_responsive_adv,qode-content-sidebar-responsive,columns-4,qode-theme-ver-1.0,qode-theme-leap,wpb-js-composer js-comp-ver-5.1.1,vc_responsive
 

april 2015

We previously discovered several TRPC1/4/5 modulators steroids, including the xanthine based small molecule Pico145, a potent TRPC1/4/5 channel inhibitor that shows selectivity for heteromeric TRPC1:C4 channels over other TRPC1/4/5 channels. This will enable future development of small molecules that target specific TRPC4 or TRPC5 channels,...